Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury.
Cysteinyl leukotrienes (CysLTs) have been implicated as inflammatory mediators of cardiovascular disease. Three distinct CysLT receptor subtypes transduce the actions of CysLTs but the role of the endothelial CysLT2 receptor (CysLT2R) in cardiac function is unknown. Here, we investigated the role of CysLT2R in myocardial ischemia-reperfusion (I/R) injury using transgenic (tg) mice overexpressing human CysLT2R in vascular endothelium and nontransgenic (ntg) littermates. Infarction size in tg mice increased 114% compared with ntg mice 48 hours after I/R; this increase was blocked by the CysLT receptor antagonist BAY-u9773. Injection of 125 I-albumin into the systemic circulation revealed significantly enhanced extravasation of the label in tg mice, indicating increased leakage of the coronary endothelium, combined with increased incidence of hemorrhage and cardiomyocyte apoptosis. Expression of proinflammatory genes such as Egr-1, VCAM-1, and ICAM was significantly increased in tg mice relative to ntg controls. Echocardiographic assessment 2 weeks after I/R revealed decreased anterior wall thickness in tg mice. Furthermore, the postreperfusion time constant tau of isovolumic relaxation was significantly increased in tg animals, indicating diastolic dysfunction. These results reveal that endothelium-targeted overexpression of CysLT2R aggravates myocardial I/R injury by increasing endothelial permeability and exacerbating inflammatory gene expression, leading to accelerated left ventricular remodeling, induction of peri-infarct zone cellular apoptosis, and impaired cardiac performance.
Jiang
Wei
W
Department of Physiology, 433 Botterell Hall, Stuart St., Queen's University, Kingston, ON K7L 3N6 Canada.
Hall
Sean R
SR
Moos
Michael P W
MP
Cao
Richard Yang
RY
Ishii
Satoshi
S
Ogunyankin
Kofo O
KO
Melo
Luis G
LG
Funk
Colin D
CD
D000818:Animals; D017209:Apoptosis / Q000235:genetics; D002463:Cell Membrane Permeability / Q000235:genetics; D051766:Early Growth Response Protein 1 / Q000235:genetics; D004730:Endothelium, Vascular / Q000378:metabolism*; D018799:Intercellular Adhesion Molecule-1 / Q000235:genetics; D017493:Leukocyte Common Antigens / Q000378:metabolism; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D015428:Myocardial Reperfusion Injury / Q000150:complications / Q000235:genetics* / Q000473:pathology; D009206:Myocardium / Q000378:metabolism; D032383:Myocytes, Cardiac / Q000473:pathology; D020556:Neutrophil Infiltration / Q000235:genetics; D018077:Receptors, Leukotriene / Q000235:genetics* / Q000378:metabolism; D015854:Up-Regulation / Q000502:physiology; D019010:Vascular Cell Adhesion Molecule-1 / Q000235:genetics; D018487:Ventricular Dysfunction, Left / Q000209:etiology / Q000235:genetics; D020257:Ventricular Remodeling / Q000235:genetics
D051766:Early Growth Response Protein 1; C486109:Egr1 protein, mouse; C090509:Icam1 protein, mouse; D008565:Membrane Proteins; D018077:Receptors, Leukotriene; D019010:Vascular Cell Adhesion Molecule-1; D018799:Intercellular Adhesion Molecule-1; C412375:cysteinyl leukotriene receptor 2; D017493:Leukocyte Common Antigens